MedPath

Effectiveness of Artificial Saliva plus Beta-Glucan for Treatment of Xerostomia in Older Adults

Phase 4
Completed
Conditions
Older adults with xerostomia for at least a week.
Xerostomia, Artificial saliva, Beta-glucan, antioxidant, Moisturizing effect, Total Antioxidant Capacity.
Registration Number
TCTR20230206008
Lead Sponsor
Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
51
Inclusion Criteria

1.Subjects age older than 60 years old
2.Subjects that have experienced subjective feelings of dry mouth for more than 7 days

Exclusion Criteria

1)Subjects have previous radiation therapy (head and neck area)
2)Subjects have previous chemotherapy
3)Subjects have cancer or tumor of the salivary gland.
4)Subjects have a history of systemic diseases explaining the diminished salivary flow (i.e., Sjogren syndrome, infection of the salivary glands,)
5) Pregnant or breastfeeding women
6) Decompensated systemic disorders or cognitive problems.
7)Subjects have immunodeficiency diseases
8)Subjects who are allergic to fungal or yeast

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Xerostomia Inventory (XI) 4 weeks Xerostomia Inventory (XI) score
Secondary Outcome Measures
NameTimeMethod
Clinical oral dryness score (CODS) 4 weeks Clinical oral dryness score (CODS) (0-10),Oral moisture degree in patients with dry mouth measure by oral moisture checking device 4 weeks scale(0-99.9),The whole unstimulated saliva flow rate 4 weeks ml/min,Salivary total antioxidant capacity 4 weeks Salivary TAC,Evaluation of post-use satisfaction with artificial saliva spray 4 weeks Satisfaction score(1-5)
© Copyright 2025. All Rights Reserved by MedPath